Navigation Links


Giuliani in Medical News

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

...amine with hydrophilic and lipophilic components. Shire has licensed from giuliani SpA the exclusive rights to develop and commercialize Lialda in the US, Can... XL(TM) in the UK and Ireland, and MEZAVANT(R) elsewhere outside of the US. giuliani SpA retains the development and commercialization rights in Italy. Cosmo Ph...

Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis

...amine with hydrophilic and lipophilic components. Shire has licensed from giuliani SpA the exclusive rights to develop and commercialize LIALDA in the US, Can... XL(TM) in the UK and Ireland, and MEZAVANT(R) elsewhere outside of the US. giuliani SpA retains the development and commercialization rights in Italy. Cosmo Ph...

Independent Voters Remain Worried about Health Care

...urance company (Clinton: 24%) -- Leading the coordination of recovery after a natural disaster (Clinton: 18%) Former New York Mayor Rudy giuliani -- who has since dropped out of the race -- led among Republicans (33 percent) as best suited to lead recovery efforts after a natural disaster, but t...

Election 2008: Sleep deprivation a tough opponent for presidential candidates

... WESTCHESTER, Ill. - The field of presidential contenders dwindled Wednesday when former New York Mayor Rudy giuliani and former Sen. John Edwards (D-N.C.) dropped out of the race. As Super Tuesday approaches, however, the Democratic and Republican frontrunners will ...

NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14)

.... http://www.newsweek.com/id/91667 LIVING POLITICS: "No Room for Rudy" (p. 46). Senior Political Correspondent Howard Fineman writes that, "Rudy giuliani sees Florida as his Cape Canaveral: the launching pad for his better-later-than-never campaign." "But that's where the good news ends for Giuliani," F...

DNC: Rudy Shows Again He's Out-of-Touch With America's Priorities

...ciated Press, 12/28/07] On the campaign trail, giuliani has had to defend his abysmal health care record a...ge a priority." A Record That Raises Concerns: giuliani Slashed City Health Services giuliani Cut Hospital Funding by Almost Half a Billion Doll...

New Hampshire AIDS Group Calls on Huckabee to Disavow His 1992 Statement

...to acknowledge some of these groups even exist to respect their human rights and get them the health services they need? Huckabee, Romney, McCain, and giuliani have all left this very unclear," said D'Allesandro. New Hampshire Fights AIDS is a grassroots movement of concerned citizens who are devoted ...

Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives

...d lipophilic excipients. Shire has licensed from giuliani SpA the exclusive rights to develop and commercial...VANT(TM) -- (excluding Italy) and the Pacific Rim. giuliani SpA retains the development and commercialization ... Matthew Cabrey (Shire) +1 484 595 8248 giuliani SpA ...

NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26).

... of cops and hoods and to a Catholic culture with a strict moral code but always holding out the possibility of redemption and grace. On the one hand, giuliani has been a crusader against outlaw policemen, as well as mobsters, pornographers, drug dealers, crooked businessmen and politicians and death-dealing ...

NEWSWEEK: Media Lead Sheet/November 19, 2007 Issue (on newsstands Monday, November 12)

...rophet -- James Dobson, the priest -- Rev. Billy Graham, and the kingmaker -- Pat Robertson, Michael Gerson writes. "Robertson's public endorsement of giuliani last week surprised many. It should not have. His predisposition has always been to influence Republican politics from the inside. ... But Robertson's...
Giuliani in Medical Technology

Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW

...amine with hydrophilic and lipophilic components. Shire has licensed from giuliani SpA the exclusive rights to develop and commercialize LIALDA in the US, Can... XL(TM) in the UK and Ireland, and MEZAVANT(R) elsewhere outside of the US. giuliani SpA retains the development and commercialization rights in Italy. Cosmo Ph...

New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG

...nd lipophilic excipients. Shire has licensed from giuliani SpA the exclusive rights to develop and commercial...VANT(TM) -- (excluding Italy) and the Pacific Rim. giuliani SpA retains the development and commercialization ...sit the Company's website: http://www.shire.com giuliani SpA ...

Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life

...r health care providers. Shire has licensed from giuliani SpA the exclusive rights to develop and commercial...y (Shire) +1 484 595 8248 giuliani SpA giuliani SpA, founded in 1889, is a privately owned special...

Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW

...d lipophilic excipients. Shire has licensed from giuliani SpA the exclusive rights to develop and commercial... Cabrey (Shire) +1 484 595 8248 giuliani SpA giuliani SpA, founded in 1889, is a privately owned special...

Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

...n infections. Cosmo's first MMX(tm) product that has reached the market is LIALDA(tm) / MEZAVANT(tm), a treatment for IBD that is licensed globally to giuliani and Shire Pharmaceuticals. Cosmo's proprietary MMX(tm) technology is at the core of the company's product pipeline and was developed from its expertis...
Giuliani in Biological Technology

Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis

...mulation in this class to be approved since 2000. Shire has licensed from giuliani SpA the exclusive rights to develop and commercialise LIALDA in the US, Can... XL(TM) in the UK and Ireland, and MEZAVANT(R) elsewhere outside of the US. giuliani SpA retains the development and commercialisation rights in Italy. Cosmo Ph...

NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3).

...ugh GOP hopeful Rudy Giuliani's privately owned management-consulting firm, giuliani Partners, and Qatar's government to provide "strategic advice" on counterte...e country's oil and gas pipelines and ports, is getting a lot of attention. giuliani has insisted his business dealings are "totally legal, totally ethical," bu...

Giuliani will keynote RedPrairie Corporation's user conference

... Waukesha, Wis. - Former New York City Mayor Rudolph giuliani will keynote RedShift 2006 , RedPrairie Corporation's ninth annual user ...tomotive and service parts, and pharmaceuticals. First elected in 1993, giuliani served two terms as Mayor of New York City. He was widely acclaimed for his...
Other TagsHGHswimswimsignificantlysignificantlyCOXCOX
(Date:12/16/2009)... of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 million ... included in the final Fiscal Year 2010 Defense Appropriations ... research cancers, like colorectal cancer, that are not addressed ... programs run by the U.S. Army Medical Research and ... funding for this new cancer research program was included ...
(Date:12/16/2009)... Wellcome Trust Sanger Institute announce the first comprehensive analyses ... by mutations in the DNA of cancer cells which ... a malignant melanoma and a lung cancer, reveal for ... genomes of two cancers. , Lung cancer causes around ... associated with smoking. The number of mutations found suggest ...
(Date:12/16/2009)... and Encourage Access to Quality, Cost-Effective Care , ... ... Congress have debated the best ways to rein in runaway costs ... An important part of the ongoing discussion includes how to ... providers besides doctors of medicine (MDs) or osteopathy (DOs). In ...
(Date:12/16/2009)... MassBio promote Massachusetts companies through annual marketing campaign , ... ... -- BioSpace unveiled the 2010 Genetown™ Hotbed Campaign ... , , ,Genetown is sponsored by MassBio and ... industries. The campaign places each entity’s brand on an ...
(Date:12/16/2009)... Inc., developers of the AcceleDent System , ... announced Alison Davies as its new Director of ... spent the last fourteen years of her professional ... nine years as a senior manager with ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) ,, ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4
(Date:12/16/2009)... School of Medicine researcher will lead the coordinating center ... in the field of stem cell research. Michael L. ... chosen by the National Heart, Lung and Blood Institute ... national experts, which will be called the NHLBI Progenitor ... by a $30 million grant over seven years. ...
(Date:12/16/2009)... Calif. and PALM HARBOR, Fla., Dec. 2 ... Bulletin Board: CICI), a leading supplier of ... in the financial industry* and the recognized ... Systems Inc. ("Docubase"), a leading International Electronic ... that they have entered an agreement to ...
(Date:12/16/2009)... 9 BIO-key International, Inc. (OTC ... biometric identification solutions, today announced that SC ... security publications, named BIO-key International the 2009 ... Control sub-category Biometrics. ,, (Logo: ... technology editor, SC Magazine, "Biometric providers have ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Varian Inc to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results 13121 1BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor 52213 1BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor 52213 2Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 52211 1Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 52211 2Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 52211 3
Other Contentsarchesarchesfallenfallenfallenfallenfaintingfaintingfallsfallsfallsfallsfallsfallsfallshypercholesterolemiapracticepracticepracticepracticepracticepracticepracticepracticepractice